Terms: = Brain cancer AND Neurokinin
34 results:
1. Impose of KNDy/GnRH neural circuit in PCOS, ageing, cancer and Alzheimer's disease: StAR actions in prevention of neuroendocrine dysfunction.
Panda SP; Kesharwani A; Singh GD; Prasanth D; Vatchavai BR; Kumari PVK; Panda SK; Mallick SP
Ageing Res Rev; 2023 Dec; 92():102086. PubMed ID: 37821047
[TBL] [Abstract] [Full Text] [Related]
2. Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma.
Mehboob R; Kurdi M; Baeesa S; Fawzy Halawa T; Tanvir I; Maghrabi Y; Hakamy S; Saeedi R; Moshref R; Nasief H; Hassan A; Waseem H; Rasool S; Bahakeem B; Faizo E; Katib Y; Bamaga A; Aldardeir N
Folia Neuropathol; 2022; 60(2):165-176. PubMed ID: 35950469
[TBL] [Abstract] [Full Text] [Related]
3. neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme.
Afshari AR; Motamed-Sanaye A; Sabri H; Soltani A; Karkon-Shayan S; Radvar S; Javid H; Mollazadeh H; Sathyapalan T; Sahebkar A
Curr Med Chem; 2021; 28(24):4877-4892. PubMed ID: 33441062
[TBL] [Abstract] [Full Text] [Related]
4. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
Nizam E; Köksoy S; Erin N
Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of Kisspeptin Neurons in the Human Rostral Hypothalamus.
Rumpler É; Skrapits K; Takács S; Göcz B; Trinh SH; Rácz G; Matolcsy A; Kozma Z; Ciofi P; Dhillo WS; Hrabovszky E
Neuroendocrinology; 2021; 111(3):249-262. PubMed ID: 32299085
[TBL] [Abstract] [Full Text] [Related]
6. neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.
Vincenzi B; Trower M; Duggal A; Guglielmini P; Harris P; Jackson D; Lacouture ME; Ratti E; Tonini G; Wood A; Ständer S
BMJ Open; 2020 Feb; 10(2):e030114. PubMed ID: 32034016
[TBL] [Abstract] [Full Text] [Related]
7. Yokukansan, a Japanese Herbal Medicine, Suppresses Substance PInduced Production of Interleukin-6 and Interleukin-8 by Human U373 MG Glioblastoma Astrocytoma Cells.
Yamaguchi K; Yamazaki S; Kumakura S; Someya A; Iseki M; Inada E; Nagaoka I
Endocr Metab Immune Disord Drug Targets; 2020; 20(7):1073-1080. PubMed ID: 32003704
[TBL] [Abstract] [Full Text] [Related]
8. Endocytic recycling prevents copper accumulation in astrocytoma cells stimulated with copper-bound neurokinin B.
Menon R; Christofides K; Jones CE
Biochem Biophys Res Commun; 2020 Mar; 523(3):739-744. PubMed ID: 31952788
[TBL] [Abstract] [Full Text] [Related]
9. Evolution of antiemetic studies for radiation-induced nausea and vomiting within an outpatient palliative radiotherapy clinic.
McKenzie E; Chan D; Parsafar S; Razvi Y; McFarlane T; Rico V; Pasetka M; DeAngelis C; Chow E
Support Care Cancer; 2019 Sep; 27(9):3245-3252. PubMed ID: 31119459
[TBL] [Abstract] [Full Text] [Related]
10. Managing vasomotor symptoms in women after cancer.
Pinkerton JV; Santen RJ
Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
[TBL] [Abstract] [Full Text] [Related]
11. Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Baron-Hay S; Aapro M; Bernareggi A; Schwartzberg L
Support Care Cancer; 2019 Apr; 27(4):1309-1317. PubMed ID: 30685793
[TBL] [Abstract] [Full Text] [Related]
12. Glioma and neurokinin-1 Receptor Antagonists: A New Therapeutic Approach.
Muñoz M; Coveñas R
Anticancer Agents Med Chem; 2019; 19(1):92-100. PubMed ID: 29692265
[TBL] [Abstract] [Full Text] [Related]
13. In vitro evaluation of
Majkowska-Pilip A; Rius M; Bruchertseifer F; Apostolidis C; Weis M; Bonelli M; Laurenza M; Królicki L; Morgenstern A
Chem Biol Drug Des; 2018 Jul; 92(1):1344-1356. PubMed ID: 29611298
[TBL] [Abstract] [Full Text] [Related]
14. Managing Menopausal Symptoms and Associated Clinical Issues in Breast cancer Survivors.
Santen RJ; Stuenkel CA; Davis SR; Pinkerton JV; Gompel A; Lumsden MA
J Clin Endocrinol Metab; 2017 Oct; 102(10):3647-3661. PubMed ID: 28934376
[TBL] [Abstract] [Full Text] [Related]
15. Possible role of aprepitant for intractable nausea and vomiting following whole brain radiotherapy-a case report.
Ahuja D; Bharati SJ; Gupta N; Kumar R; Bhatnagar S
Ann Palliat Med; 2016 Oct; 5(4):315-318. PubMed ID: 27701875
[TBL] [Abstract] [Full Text] [Related]
16. Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron).
Rojas C; Slusher BS
Cancer Treat Rev; 2015 Dec; 41(10):904-13. PubMed ID: 26442475
[TBL] [Abstract] [Full Text] [Related]
17. 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Navari RM
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2738-46. PubMed ID: 25838122
[TBL] [Abstract] [Full Text] [Related]
18. Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.
Martinez VG; O'Driscoll L
Clin Chem; 2015 Mar; 61(3):471-82. PubMed ID: 25605682
[TBL] [Abstract] [Full Text] [Related]
19. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Kast RE; Karpel-Massler G; Halatsch ME
Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
[TBL] [Abstract] [Full Text] [Related]
20. Aprepitant reduces chemotherapy-induced vomiting in children and young adults with brain tumors.
Duggin K; Tickle K; Norman G; Yang J; Wang C; Cross SJ; Gajjar A; Mandrell B
J Pediatr Oncol Nurs; 2014; 31(5):277-83. PubMed ID: 24972782
[TBL] [Abstract] [Full Text] [Related]
[Next]
